Education
About Us
Working with TipRanks
Follow Us
Butterfly Network (BFLY)
NYSE:BFLY
BFLY Stock Chart & Stats
$3.82
-$0.17(-4.21%)
At close: 4:00 PM EST
$3.82
-$0.17(-4.21%)
Day’s Range― - ―
52-Week Range$1.32 - $5.03
Previous CloseN/A
Volume2.30M
Average Volume (3M)4.74M
Market Cap
$1.00B
Enterprise Value$841.74M
Total Cash (Recent Filing)$144.23M
Total Debt (Recent Filing)$21.03M
Price to Earnings (P/E)―
Beta1.84
Next Earnings
Mar 04, 2026EPS Estimate
-0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding226,175,170
10 Day Avg. Volume4,364,789
30 Day Avg. Volume4,738,888
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)3.91
Price to Sales (P/S)8.05
P/FCF Ratio-14.87
Enterprise Value/Market Cap0.84
Enterprise Value/Revenue9.52
Enterprise Value/Gross Profit22.01
Enterprise Value/Ebitda-12.08
Forecast
1Y Price Target
$5.08Price Target Upside32.98% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improving Financial And Operational MetricsRevenue growth, higher gross margins and reduced cash burn combined with a substantial cash balance point to improving financial durability and more runway for commercialization efforts.
Market Expansion Via Semiconductor And AI-imagingLicensing ultrasound-on-chip technology for non-medical, edge-AI applications signals a strategic pivot into semiconductor and AI-imaging markets that could greatly expand the company’s addressable market beyond point-of-care ultrasound.
Strategic Partnership And FinancingCo-development and licensing agreement with a leading generative-AI firm provides $65 million in guaranteed, non-dilutive revenue that strengthens the balance sheet and supports further product investment.
Bears Say
Clinical Adoption RiskSlow adoption of new medical practices could limit uptake of point-of-care devices and delay expected revenue from hospital and enterprise deployments.
Competitive PressureLarger, established medical-device and semiconductor competitors could challenge pricing, slow market penetration and complicate enterprise deal momentum.
Execution And Intellectual Property UncertaintyUncertain timing to monetize opportunities beyond point-of-care and potential intellectual property questions could postpone or reduce expected revenue from new semiconductor and non-medical use cases.
Butterfly Network News
BFLY FAQ
What was Butterfly Network’s price range in the past 12 months?
Butterfly Network lowest stock price was $1.32 and its highest was $5.03 in the past 12 months.
What is Butterfly Network’s market cap?
Butterfly Network’s market cap is $1.00B.
When is Butterfly Network’s upcoming earnings report date?
Butterfly Network’s upcoming earnings report date is Mar 04, 2026 which is in 29 days.
How were Butterfly Network’s earnings last quarter?
Butterfly Network released its earnings results on Oct 31, 2025. The company reported -$0.04 earnings per share for the quarter, beating the consensus estimate of -$0.043 by $0.003.
Is Butterfly Network overvalued?
According to Wall Street analysts Butterfly Network’s price is currently Undervalued.
Does Butterfly Network pay dividends?
Butterfly Network does not currently pay dividends.
What is Butterfly Network’s EPS estimate?
Butterfly Network’s EPS estimate is -0.05.
How many shares outstanding does Butterfly Network have?
Butterfly Network has 226,175,170 shares outstanding.
What happened to Butterfly Network’s price movement after its last earnings report?
Butterfly Network reported an EPS of -$0.04 in its last earnings report, beating expectations of -$0.043. Following the earnings report the stock price went up 31.863%.
Which hedge fund is a major shareholder of Butterfly Network?
Currently, no hedge funds are holding shares in BFLY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Butterfly Network Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$5.08 (32.98% Upside)
$5.08 (32.98% Upside)
Blogger Sentiment
Bullish
BFLY Sentiment 60%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 453.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $11.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days <0.1%
Last 30 Days ▼ 2.1%
Last 30 Days ▼ 2.1%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-4.26%
12-Months-Change
Fundamentals
Return on Equity
-41.42%
Trailing 12-Months
Asset Growth
9.32%
Trailing 12-Months
Company Description
Butterfly Network
Butterfly Network, Inc., a digital health company, develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+, a point-of-care ultrasound imaging device that connects with a smartphone, tablet, and hospital computer system; and Butterfly Blueprint, a system-wide ultrasound platform with Compass software that integrates into a healthcare system's clinical and administrative infrastructure. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions, to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as clinical support and services. Butterfly Network, Inc. was incorporated in 2011 and is headquartered in Guilford, Connecticut.
BFLY Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with notable achievements in revenue growth and AI strategy, counterbalanced by challenges related to macroeconomic factors and inventory write-offs. Despite delays in enterprise deals, the company remains optimistic about future prospects with new product developments and market expansion.View all BFLY earnings summariesBFLY Stock 12 Month Forecast
Average Price Target
$5.08
▲(32.98% Upside)
Technical Analysis
Varex Imaging
―
OrthoPediatrics
―
Bioventus
―
Treace Medical Concepts
―
Ceribell, Inc.
―
Ownership Overview
29.90% Insiders
7.05% Mutual Funds
0.14% Other Institutional Investors
50.32% Public Companies and
Individual Investors